RIL
SNDX icon

Rothschild Investment LLC’s Syndax Pharmaceuticals SNDX Stock Holding History

Rothschild Investment LLC’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47K Sell
113
-182
-62% -$3.79K ﹤0.01% 2666
2026
Q1 		$6.89K Buy
295
+170
+136% +$3.69K ﹤0.01% 1889
2025
Q4 		$2.63K Buy
125
+30
+32% +$523 ﹤0.01% 2225
2025
Q3 		$1.46K Buy
95
+40
+73% +$524 ﹤0.01% 2413
2025
Q2 		$515 Sell
55
-75
-58% -$825 ﹤0.01% 2737
2025
Q1 		$1.6K Buy
130
+95
+271% +$1.34K ﹤0.01% 2036
2024
Q4 		$463 Sell
35
-35
-50% -$599 ﹤0.01% 2566
2024
Q3 		$1.35K Buy
70
+45
+180% +$930 ﹤0.01% 1955
2024
Q2 		$513 Buy
25
+20
+400% +$419 ﹤0.01% 2000
2024
Q1 		$119 Buy
+5
New +$112 ﹤0.01% 2111

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
VIG
Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return

Rothschild Investment LLC's SNDX Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Syndax Pharmaceuticals (SNDX) stake by 62% in Q2 2026, selling an estimated $3.79K and leaving 113 shares worth $2.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2666.

Rothschild Investment LLC first reported a position in SNDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.89K in Q1 2026. 67 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Rothschild Investment LLC held 113 shares of Syndax Pharmaceuticals worth $2.47K as of Q2 2026.
  • Rothschild Investment LLC sold 182 Syndax Pharmaceuticals shares in Q2 2026, an estimated $3.79K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2666 holding.
  • Rothschild Investment LLC first reported a position in Syndax Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's Syndax Pharmaceuticals position peaked at $6.89K in Q1 2026.
  • 67 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.